Staging and classification of lymphoma.

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Lymphoma diagnosis and management rely heavily on accurate pathological classification.
• Previous classification systems lacked a unified international consensus.
• Advances in cytogenetics, molecular biology, and immunology have refined lymphoma understanding.

Purpose of the Study:

• To provide a historical overview of lymphoma classification systems.
• To summarize recent classification schemes, including the REAL and WHO classifications.
• To highlight the importance of current classifications for diagnosis, staging, and management.

Main Methods:

• Review of historical and recent literature on lymphoma classification.
• Summary of key features of the Revised European-American Classification of Lymphoid Neoplasms (REAL).
• Analysis of the World Health Organization (WHO) classification updates for lymphomas.

Main Results:

• The REAL and WHO classifications represent international consensus, incorporating modern diagnostic techniques.
• These systems have advanced the understanding and categorization of lymphoid neoplasms.
• The review details new lymphoma entities, staging methods, and prognostic criteria.

Conclusions:

• Adoption of current WHO/REAL classification is vital for consistent lymphoma diagnosis and patient management.
• Understanding these classifications refines the application of imaging in lymphoma staging and monitoring.
• This review serves as a guide to current lymphoma classification, aiding clinicians and researchers.